Prostate Active Surveillance Study (PASS) Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly. Information obtained in this study may help develop better diagnostic tests to predict the outcomes of prostate cancer.

To be eligible for the study, men must have previously untreated, clinically localized prostate cancer. Participants will be evaluated on a routine schedule of physical exams, PSA measurements and prostate biopsies. Biospecimens (blood, urine, tissue) will be collected and stored for use in biomarker studies. For more information about PASS, including contact information for each study site, please visit http://clinicaltrials.gov/ct2/show/NCT00756665 or http://www.canaryfoundation.org/prostate-clinical-studies.cfm.

The PASS study is sponsored by the Canary Foundation, a nonprofit organization that funds research in early cancer detection, and coordinated by the National Cancer Institute’s Early Detection Research Network (EDRN).